Pharma Launch Strategy

FAQ

Why is launch strategy critical in today’s market?

Because the environment is more competitive, regulated, and payer-driven than ever. Strong launch execution impacts:

  • Speed to patient access
  • Market penetration
  • Brand perception
  • Revenue trajectory

Most underperforming brands fail due to access and distribution missteps—not clinical shortcomings.

When should pharma companies start preparing for launch?

Planning typically begins 24–36 months before approval, often starting as early as Phase II.
Payer evidence generation should start even earlier to ensure requirements are met for coverage decisions.

What role does market access play in launch strategy?

Market access is central. It defines:

  • Formulary placement
  • Utilization management policies
  • Pricing and discounting expectations
  • Distribution and channel strategy
  • HCP adoption through reduced administrative burden

Poor access can stall even the most effective therapies.

Related Links

Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch